Peptides are at the cutting edge of contemporary research for new potent, selective, and
safe therapeutical agents. Their rise has reshaped the pharmaceutical landscape, providing …

Anticancer peptides (ACPs) are promising antitumor drugs owning to their great cancer cell
targeting and anticancer effects as well as low drug resistance. However, many of the ACPs …

During the last few decades, several efforts have been made towards develo**
biocompatible materials. Among them, peptide amphiphiles (PAs) constitute a novel …

Anticancer peptides (ACPs) perform a promising role in discovering anti-cancer drugs. The
growing research on ACPs as therapeutic agent is increasing due to its minimal side effects …

Current anticancer research shows that a combination of multiple treatment methods can
greatly improve the killing of tumor cells. Using the latest microfluidic swirl mixer technology …

Antimicrobial resistance (AMR) has become a major global health concern prompting the
quest for new antibiotics with higher efficiency and less proneness to drug resistance …

Designed peptides are promising biomaterials for biomedical applications. The amphiphilic
cationic antimicrobial peptide (AMP), A 9 K, can self-assemble into nano-rod structures and …

The usage of peptide-based drugs to combat cancer is gaining significance in the
pharmaceutical industry. The collateral damage caused to normal cells due to the use of …

Anticancer peptides (ACPs) have regarded as a new generation of promising antitumor
drugs due to the unique mode of action. The main challenge is to develop potential …

Cancer prevails as one of the major health concerns worldwide due to the consistent rise in
incidence and lack of effective therapies. Previous studies identified the peptides KLKKNL …